China Biologic Products Ret. on equity
What is the Ret. on equity of China Biologic Products?
The Ret. on equity of China Biologic Products Holdings, Inc. is 8.25%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Miscellaneous sector on LSE compared to China Biologic Products
Companies with ret. on equity similar to China Biologic Products
- Sumitomo has Ret. on equity of 8.24%
- Luzhou Bank Co has Ret. on equity of 8.24%
- Warehouse REIT PLC has Ret. on equity of 8.24%
- Worthington Enterprises has Ret. on equity of 8.24%
- Flughafen Wien Aktiengesellschaft has Ret. on equity of 8.24%
- Scansource has Ret. on equity of 8.25%
- China Biologic Products has Ret. on equity of 8.25%
- Fauquier Bankshares has Ret. on equity of 8.25%
- Brickability Plc has Ret. on equity of 8.25%
- The South India Paper Mills has Ret. on equity of 8.25%
- Baidu Inc has Ret. on equity of 8.25%
- Maruti Suzuki India has Ret. on equity of 8.25%
- ATI Airtest Technologies has Ret. on equity of 8.26%